Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, ...

A troubling sex trend is making its way across college campuses nationwide, and doctors are concerned. Healthy college men ...

Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...

Dr Reddy's Laboratories has announced the launch of Toripalimab in India, a new biological entity (NBE) that is used for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma ...

Doctors at Emory University Healthcare made history by becoming the first group in the U.S. to successfully implant a new ...

Dr Reddys Laboratories announced the launch of Toripalimab in India.

Bolivia's highest court on Wednesday approved the extradition to the United States of a former anti-narcotics chief on ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...